Home›Companies›Healthcare›Lab Angelus

Lab Angelus, Inc.

Software that coordinates cancer testing between pathology and molecular laboratories.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Aug 14, 2026·Suggest an edit

About Lab Angelus

Lab Angelus is a private company based in Merriam, Kansas, incorporated in 2023 in Delaware. It has reported $350,000 raised in one offering on Form D since August 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 1, 2026Aug 14, 2026$350,000of $1.0M target1$350KOptions, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lab Angelus's Form D filed Aug 14, 2026.

SC
Samuel Caughron
President and director

Sources

  1. SECLab Angelus, Inc. filing history
  2. CompanyLabDispatch privacy policy
  3. CompanyLabDispatch